Elimination of corticosteroids after ischemia, by removal of the adrenals, has been reported to preserve neuronal integrity later. To establish the therapeutic potential of this observation, the authors address two questions: first, whether clinically more relevant steroid manipulations after ischemia exert similar protective effects, and second, whether changes in synaptic functioning occur along with structural alterations. To test this, the authors treated animals immediately after hyp oxia-ischemia with (I) the steroid synthesis inhibitor metyra pone, (2) the synthetic glucocorticoid receptor agonist dexa methasone, (3) the selective glucocorticoid antagonist RU 38486, or (4) corticosterone. Metyrapone, but none of the other compounds, attenuated the occurrence of seizures immediately after ischemia, Twenty-four hours after hypoxia-ischemia,
Corticosteroid hormones are secreted from the adrenal glands, readily cross the blood-brain barrier, and bind to both corticosteroid receptor types in the brain: the min eralocorticoid receptor (MR) and the glucocorticoid re ceptor (GR), which are co-localized in hippocampal neu rons (McEwen et aI., 1986; de Kloet, 1991) , Because of a difference in affinity of these receptor types for corti costerone, low levels of corticosterone predominantly occupy MR, whereas GR are progressively occupied with higher hormone levels (De Kloet, 1991) , On bind ing of corticosterone to MR or GR, the hormone modu lates signal transduction, cellular viability, and hippo-CA I hippocampal field potentials in response to stimulation of Schaffer/commissural fibers were found to be reduced. The attenuation of synaptic transmission was partly prevented by metyrapone. None of the other experimental treatments influ enced the impaired synaptic function, Gross morphologic analysis revealed no differences in the loss of neuronal struc ture between the experimental groups at this time point. Taken together, these data suggest that metyrapone preserves neuronal functioning despite loss of neuronal structure. The authors ten tatively conclude that preventing the ongoing production of steroids shortly after ischemia can delay and attenuate the ap pearance of ischemia-related pathology, Key Words: Isch emia-Corticosteroids-Hippocampus-Seizures-Epilepsy, campal structure (Joels and De KIoet, 1994; McEwen and Sapolsky, 1995) , Earlier studies provide evidence that elevated gluco corticoid levels increase vulnerability of hippocampal neurons in response to challenges such as ischemia (Sa polsky and Pulsinelli, 1985; Morse and Davis, 1990) , Conversely, treatment with steroid synthesis inhibitors before the ischemic insult, to prevent the production of corticosteroids during ischemia, preserves neuronal in tegrity and prevents the occurrence of seizures (Krugers et aI., 1995; Smith-Swintosky et aI., 1996; Krugers et aI., 1998) , Both in vitro and in vivo studies point to the GR as a mediator of these damaging effects of corticosterone (Koide et aI., 1986; Packan and Sapolsky, 1990; Adachi et aI., 1998) , An important question from the therapeutic point of view is whether modulation of plasma corticosterone levels after ischemia is as effective as treatment before the ischemic insult. Preliminary evidence suggests that removal of the adrenal glands (adrenalectomy) after isch emia preserves neuronal integrity later on (Sapolsky and Pulsinelli, 1985; Morse and Davis, 1990 ), In the current study, we elaborate these preliminary findings: First, we studied whether treatment with the steroid synthesis in hibitor metyrapone or with the GR-antagonist RU 38486 after the ischemic insult-a clinically more relevant al ternative for adrenalectomy-can delay or attenuate postischemic pathology. We also tested the efficacy of the synthetic GR-agonist dexamethasone. Dexametha sone is hampered in its transport across the intact blood brain barrier by the mdr-la protein (Meijer et aI., 1998) ; consequently, it indirectly suppresses production of en dogenous corticosterone by a negative feedback action at the level of the pituitary but lacks GR agonistic actions in the brain. Therefore, we predict that dexamethasone sup presses the corticosterone output, which could poten tially reduce postischemic pathology. Second, we studied the effect of these postischemic steroid treatments not only on structural, but also on functional parameters in the hippocampus, a region that is known to display se vere ischemia-induced pathology. To this purpose, we recorded field potentials in the hippocampal CA 1 area in vitro in response to stimulation of Schaffer collateral/ commissural fibers, 24 hours after hypoxia-ischemia. At the same time point, we determined morphologic alter ations in the hippocampus using Nissl staining and im munohistochemical analysis for the structural protein, microtubule-associated protein 2 (MAP2).
MATERIALS AND METHODS

Experimental animals
All experiments were approved by the Committee on Animal Bio-Ethics of the University of Amsterdam. Male Wi star rats (325 to 375 g) were housed individually at a light-dark regime (8 hours/20 hours) and fed ad libitum. Surgical procedures were performed between 9 and 11 hours (when basal plasma corti costerone levels are low). Immediately after hypoxia-ischemia, 11 animals (ischemia plus vehicle [Isch + VehJ) received an injection with sesame oil (0.25 mL), whereas 12 animals (isch emia plus corticosterone [Isch + Cort]) received an injection with corticosterone at a dose (40 mg/kg subcutaneously) known to elevate steroid levels over a prolonged period (Sapolsky and Pulsinelli, 1985; Krugers et aI., 1998) . Ten animals (lsch + Met) received an injection with metyrapone (150 mg/kg sub cutaneously), which inhibits the rise in steroid levels (Krugers et aI., 1998) , and 13 animals (Isch + RU 38486) received an injection with RU 38486 at a dose (25 mg/kg, subcutaneously) known to block the GR (Ratka et aI., 1989) . Seven animals were injected with the synthetic GR agonist dexamethasone (10 ].1g/kg), which blocks stress-induced pituitary corticotropin re lease, resulting in reduced adrenal corticosterone output (De KIoet et aI., 1975; Meijer et aI., 1998) . Moreover, eight animals were exposed to normoxia (norm + Veh) and received an in jection with vehicle. These animals were controls for surgery.
Hypoxia-ischemia procedure
Hypoxia-ischemia was induced using a modified Levine model in which temporary unilateral carotid artery ligation is combined with hypoxic ventilation (Dijkhuizen et aI., 1998; Krugers et aI., 1998) . This procedure reduces CBF at the oc cluded side during hypoxia-ischemia, thereby inducing a uni lateral global hemispheric ischemia (Dijkhuizen et aI., 1998) .
Animals were anesthetized using halothane (2%) in a mixture of 30% O2 and 70% N20. The right arteria femoral is was can nulated for continuous blood pressure monitoring during the normoxia and hypoxia-ischemia periods (Hewlett Packard Pressure transducer, Boeblingen, Germany). Animals were in tubated and subsequently ventilated (Infant ventilator MK2, Loosco, Amsterdam, The Netherlands) for 10 minutes with 30% O2 and 70% N20 (first normoxia period), next for 20 minutes with 10% O2 and 90% N20 (hypoxia), and subse quently for 5 minutes with 30% O2 and 70% N20 (second normoxia period). During the hypoxia period, the right carotid artery was occluded, thereby inducing hypoxia-ischemia. The rectal temperature was maintained between 36.0° and 37.0°C. Blood samples were taken immediately after the second nor moxia period to measure plasma corticosterone levels. The blood samples were transferred to centrifuge tubes containing 10 mL of heparin solution (500 VlmL) and centrifuged for 20 minutes at 3500 g. The supernatant was stored at -20°C for analysis of plasma corticosterone levels using a radioactive immunoassay.
Seizures
Hypoxia-ischemia evokes convulsions after the insult (Krugers et aI., 1995; Krugers et aI., 1998) . To establish wheth er modulation of steroid levels or blockade of the GR affects the incidence of these convulsions, we recorded the number of animals per group that displayed visible seizures from the pe riod after hypoxia-ischemia until perfusion 24 hours later using a video camera. In addition, the animals were subdivided into three categories: (I) no seizures, (2) I to 50 seizures, and (3) more than 50 seizures during the first 4 hours after ischemia.
Electrophysiologic procedures
Twenty-four hours after hypoxia-ischemia, animals were de capitated, and trunk blood was collected to determine plasma corticosterone levels. The brains were quickly removed and chilled in carbogenated (95% O2 and 5% CO2) artificial cere brospinal fluid (aCSF) at 4°C containing (in millimolar amounts): NaCI (120), KCI (3.5), MgS04 (1.3), NaH2P04 (1 .25), CaCI2 (2.5), D-glucose (10), and NaHC03 (25). Next, hippocampal slices (400 [Lm) were prepared with a vibroslicer (Campden Instruments, Ltd., Loughborough, U.K.) and stored at room temperature in carbogenated aCSF. After an equilibra tion period of at least 1 hour, one slice at a time was transferred to a recording chamber, which was continuously perfused with carbogenated aCSF (2 to 3 mUmin). The temperature in the recording chamber was maintained between 30° and 32°C. The slice was fixed between two nylon meshes and kept submerged.
Schaffer collateral/commissural fibers were stimulated by a bipolar stainless steel stimulation electrode (60 [Lm diameter) that delivered l50-microsecond pulses (Krugers et aI., 1997) . The evoked field potentials were recorded with aCSF-filled glass electrodes (impedance approximately 2 MD). The popu lation spike (PS) and field excitatory postsynaptic potential (fEPSP) were recorded in stratum pyramidale and stratum ra diatum, respectively. The amplitude of the PS and slope of the fEPSP were determined as shown in Figs. IA and lB.
The stimulation protocols, data acquisition, and analysis of the evoked potentials were performed with an Atari computer with in-house developed software. A schematic overview of the experimental protocols is illustrated in Fig. ID .
Recording of field potentials was started at least 15 minutes after placing the stimulation and recording electrodes. To de termine the stimulus intensity that evokes half-maximal and maximal field potential responses, an input-output (10) curve Stimulus intensity (arb. units) was constructed that comprised 10 stimulus intensities (interval of 10 seconds) ranging from threshold to maximal stimulus intensities. The relation between stimulus intensity and the evoked response was fit by a sigmoidal function:
Rma 'Y is the maximal response, ih is the intensity at which half maximal response is observed, and S represents an index pro portional to the slope of the 10 curve ( Fig. lC) . During the experiment, stimuli were delivered with half-maximal stimulus intensity determined at the start of the experiment unless stated otherwise. Next, field potentials were recorded during 10 min utes with stimuli delivered at an interval of 30 seconds. In all experiments discussed in this study, PS amplitudes and tEPSP varied by less than 20% during this period. After this period, a second 10 curve was followed by the response to paired-pulse (PP) stimulation, delivered at half-maximal stimulus intensity and maximal stimulus intensity with an interstimulus interval of 20 milliseconds. The ratio of the PS amplitudes or slope of the tEPSP measured after PP stimulation was determined as indicated in Figs. lA and lB.
Histology
In addition to the slices used for electrophysiologic record ings, four slices (i.e., two 400-j.Lm sections from both the ipsi lateral and contralateral side) were kept in 4% paraformalde hyde in 0.05 mollL phosphate buffer (pH 7.4) for 24 hours to determine morphologic alterations. After overnight fixation, one slice from the ipsilateral and contralateral side was trans ferred to 0.1 mollL phosphate-buffered saline (pH 7.4) contain ing 0.1 % sodium azide. In these sections, we studied changes in the immunocytochemical distribution of the cytoskeletal pro tein MAP2. The two remaining sections were used for Nissl staining. The 400-j.Lm sections were cryoprotected by overnight storage in 30% sucrose in 0.1 mollL phosphate buffer (pH 7.4), cut to 30-j.Lm thick coronal sections at -15DC using a cryostat microtome, and collected in 4% paraformaldehyde in 0.05 mollL phosphate buffer (pH 7.4) for cresylviolet staining, or in 0.1 mollL phosphate-buffered saline (PBS) containing 0.1 % sodium azide for MAP2 immunocytochemical study. Immuno cytochemical staining for the microtubule associated protein MAP2 was performed on free-floating sections as described
later, all steps being identical for all animals. The tissue sec tions were preincubated for 20 minutes in 0.1 % H202 in 0.05 mollL PBS, subsequently rinsed in PBS, and immersed in 5% normal sheep serum (Sigma Chemical Co., St. Louis, MO, U.S.A.) in PBS for 30 minutes to reduce background staining. Next, the sections were incubated with the first antibody (monoclonal mouse anti-MAP2, clone HM-2, Sigma) and di luted 1 :500 in PBS and 1 % normal sheep serum overnight at 4 DC under gentle movement of the incubation medium. After the primary antibody incubation, sections were rinsed in PBS and again preincubated with 5% normal sheep serum for 30 minutes before exposure to biotinylated sheep anti-mouse im munoglobulin G (Amersham, diluted I :200) in PBS for 2 hours at room temperature. Thereafter, the sections were thoroughly rinsed in PBS and incubated in streptavidin-horseradish per oxidase (Zymed, diluted ] :200) in PBS for 2 hours at room temperature. Finally, after subsequent rinsing in PBS and 0.05 mollL Tris-buffer (pH 7.4), the sections were processed by the diaminobenzidine-H202 reaction (30 mg of diamininobenzi dine and 0.01 % H20ilOO mL 0.05 mollL Tris-buffer), guided by a visual check.
The current histologic procedures did not allow accurate quantitative analysis of the observed damage. We settled for a conservative qualitative analysis in which two investigators ex amined the Nissl-stained and MAP2 immunostained sections of each animal in parallel, in a blind fashion. Histologic sections were assigned to one of the following classes:
No damage: The histologic analysis of the ipsilateral side did not reveal any difference with the contralateral side of the same animal and with control sections from normoxia treated animals. Moderate damage: Nissl staining revealed loss of integrity in the dentate gyrus (DG), although no apparent irregularly shaped pyramidal CA I neurons are present compared with the contralateral side. Severe damage: Nissl staining showed pyknotic cells in the DG and irregularly shaped pyramidal CAl cells; MAP2 immu nostaining was absent in (part of) the DG and faint in the CAl area. 
Statistics
All data are expressed as mean ± SD. Blood pressure and rectal temperature were analyzed using analysis of variance with repeated measures. The other parameters (plasma cortico steroid levels, maximal values of the PS amplitude, slope of the fEPSP, slope factor S, and half-maximal stimulation intensity of the 10 curves and PP responses) were analyzed by one-way analysis of variance followed by Fisher's test. Values of P < 0.05 were considered to be significant.
RESULTS
Physiologic values and plasma corticosterone levels
Blood pressure was stable during the first normoxia period ( Fig. 2A) . During hypoxia-ischemia, however, blood pressure dropped significantly compared with the animals that were exposed to normoxia but returned to pre-hypoxia-ischemia levels during the second normoxia period. No differences were present between the differ ent groups exposed to hypoxia-ischemia. The rectal tem perature, which was not significantly different between the experimental groups, remained stable during the sur gical procedures (Fig. 2B ).
Blood samples were taken immediately after hypoxia ischemia and after decapitation to measure plasma cor ticosteroid levels. Analysis of the corticosterone levels of all animals exposed to hypoxia-ischemia did not reveal statistically significant differences between the experi mental groups at the two time points studied (Figs. 3A and 3B) . Analyzing the levels of the animals included for electrophysiologic measurements yielded significantly elevated steroid levels immediately after decapitation in corticosterone-treated animals over normoxia-treated, as well as vehicle-, metyrapone-, and dexamethasone treated ischemic animals ([F(5,42) = 2.565; P = 0.04], data not shown).
Seizures
Hypoxia-ischemia elicited visible seizures as reported previously (Krugers et a!., 1995; Krugers et a!., 1998) . These seizures were characterized by spinning of the animal around its body axis, jerking movements, or clonic contractions of the paws. In general, these seizures were intermittent and lasted less than 30 seconds. Over the entire 24 hours after ischemia, the incidence of these seizures was comparable between the experimental groups (Table I) . However, during the first 4 hours after ischemia, the lowest incidence of seizures was found in the animals treated with metyrapone ( Table I) . Detailed analysis of the number of seizures during these first 4 hours after ischemia reveals that only one metyrapone treated animal showed more than 50 seizures ( Fig. 4) , whereas most of the metyrapone-treated animals did not display seizures during the first hours after ischemia, pointing to a temporary beneficial effect of metyrapone. Plasma corticosterone levels were comparable between the ex perimental groups both immediately and 24 hours after ischemia. The numbers indicate the animals displaying seizures over the entire 24 hours (left), during the first 4 hours after hypoxia-ischemia (middle) or immediately before decapitation (right). Cort, corticosterone; Isch, ischemia; Met, metyrapone; norm, normoxia; veh, vehicle.
Input-output curves of population spike amplitude and slope of the field EPSP In the 4-to 24-hour period after hypoxia-ischemia, one animal died in the metyrapone-and dexamethasone treated group. In addition, two animals died in the ve hicle-treated group, and three and four animals died in the RU 38486-and corticosterone-treated groups, respec tively. In the remaining animals, we studied neuronal functioning in the hippocampal CA I area after hypoxia ischemia by establishing synaptic responsiveness at both the ipsilateral and contralateral side to the occlusion. The animals reported on below exhibited a maximal PS am plitude of more than 1.2S m V and a maximal fEPSP slope more negative than -0.40 m V /ms in slices from the contralateral side to the occlusion.
Synaptic responses in slices from the side ipsilateral to the occlusion clearly were affected by ischemia; the maximal slope of the fEPSP was significantly reduced in vehicle-treated animals compared with normoxia ani mals (Fig. SD) . The steroid treatment did not influence this effect of ischemia: all steroid-treated ischemic ani mals showed a significant reduction in maximal fEPSP compared with normoxic animals. Recordings in the cell layer also yielded an ischemia-induced reduction of the maximal PS amplitude at the ipsilateral side ( Fig. SB) . However, this reduction was absent after treatment with metyrapone. These results support the view that the num ber (the dendrites) of principal cells that respond to Schaffer collateral/commissural stimulation after hy poxia-ischemia is' reduced in animals exposed to isch emia compared with animals exposed to normoxia. For all of the experimental groups, no significant differences were observed with respect to the PS amplitude and fEPSP slope in slices prepared from the contralateral side (Figs. SA and SC; [F(S,42) = 0.61; P = 0.69J, [F(S,42) = 2.22; P = 0.07], respectively). The data obtained with the 10 curve protocol were fitted with a Boltzman equation R(i) = Rma/( 1 + exp((i -ih)/(S)), yielding values for the Rmax, half-maximal stimulation intensity (ih), and a constant S, which is pro portional to the slope of the fitted curve. Reliable fits and thus values for ih and S-could be obtained only from animals where the PS amplitude was more than 0.40 m V and the fEPSP slope was more negative than -O.IS mV/ms. Table 2 shows that in all experimental groups, except the normoxia group, part of the animals were excluded from the fitting analysis at the ipsilateral side based on this criterion. Only groups comprising at least four animals were included for statistical analysis. The dexamethasone group, where only one animal showed a PS amplitude above 0.40 mV and fEPSP slope exceeding -O.IS mV/ms, was excluded from further test ing based on this criterion. From the animals where 10 curves were successfully fitted, the maximal values of the PS amplitude and fEPSP slope were, on average, reduced at the side ipsilateral to occlusion compared with the normoxia group, but these differences did not attain statistical significance. In addition, no differences in slope factor S were present at the ipsilateral or contra lateral side between the experimental groups (Table 2) . At the contralateral side, the half-maximal stimulation intensity for the PS amplitude was significantly larger in vehicle-treated ischemic animals compared with the other experimental groups. These results indicate that 10 curves of the animals from which bilateral recordings 
·2
-2.5 ·3 could be made are not different among the groups at the ipsilateral (ischemic) side.
Responses to double-pulse stimulation
The PP ratios were calculated only from the animals from which reliable signals could be obtained at the ip silateral side (PS amplitude and fEPSP slope more than 0040 m V and more negative than -0.15 m V fms, respec tively). Only groups comprising at least four animals were included for statistical analysis. In general, analysis of these responses in the CAl pyramidal cell layer, as well as in the stratum radiatum, showed facilitation of the second PS and slope of the fEPSP after stimulation at half-maximal intensity (PPh, Table 3 ). Stimulation at maximal stimulation intensity (PPm) did not evoke PP potentiation in either the cellular or dendritic layer. At the (ischemic) ipsilateral side, no changes in facilitation were present between the experimental groups at half maximal or maximal stimulation intensity in either the dendritic or cellular field.
Histology
The Nissl staining revealed histologic changes in the hippocampus at 24 hours after hypoxia-ischemia com pared with animals exposed to normoxia. At this time point, a loss of granular cells in the DO was present at the ipsilateral (occluded) side in several animals (compare Figs. 6A with 6B; Table 4 ). The cell loss was randomly present in restricted parts in both the suprapyramidal and infrapyramidal blade of the granular cell layer. Histo- Rm ax , S, and I h represent the maximal value of the 10-curve, a constant proportional to the slope, and half maximal stimulation intensity. Data are obtained from animals where the maximal ipsilateal PS amplitude was >0.40 mV and the maximal slope of the tEPSP was <-0.15 mV/ms. While at least four animals per group had to meet these criteria to perform reliable statistics, the dexamethasone group was excluded from statistical analysis. Data are expressed as mean ± SO. Cort, corticosterone; ro, input-output; Isch, ischemia; Met, metyrapone; Norm, normoxia; PS, population spike; Veh, vehicle.
* and t indicate significantly different from Norm + Veh animals and Isch + Veh animals respectively. logic alterations in the hippocampal CAl area, indicated by reduced density of the cresylviolet staining and ir regularly shaped appearance of neurons, were present in the animals that showed severe damage in the DG (com pare Figs, 6C with 6D). Steroid treatment did not affect the loss of neuronal integrity in the DG 24 hours after ischemia: both the number of animals displaying degenerative changes in the DG and the degree of cell loss in the DG were com parable between the different experimental groups (Table 4 ). Also in the CAl area, the prominent histologic alterations were comparable between the experimental grQUps.
In parallel with the Nissl staining, we observed changes in the cytoskeletal protein MAP2 after hypoxia- 1999 ischemia. Normally, MAP2 is localized to dendrites throughout the hippocampus ( Figs. 7 A and 7C) . Expo sure to hypoxia-ischemia resulted in a marked loss of MAP2 immunoreactivity that was particularly obvious in the DG molecular layer and to a lesser extent in the hippocampal CA 1 area at the side ipsilateral to occlusion (Figs. 7B and 7D). These changes in MAP2 immunore activity thereby confirm the cell loss in the DG and changes in the CA 1 area as detected with the Nissl stain ing. This relation is substantiated by individual analysis of the animals, which demonstrates that the changes de tected with Nissl staining show a similar pattern as changes in MAP2 immunoreactivity per animal. In agreement with the Nissl staining, both the number of animals that displayed a reduction in MAP2 immunore- FIG. 6. Photographs (x350) showing Nissl stainings of the dentate gyrus (A) and CA 1 pyramidal cell layer (e) of animals exposed to normoxia. Twenty-four hours after ischemia, ve hicle-treated animals display pro found loss of dentate gyrus granular cells (B), whereas clear histologic al terations also are present in the CA 1 area (D). No differences in the amount of degeneration was ob served between the different isch emic groups. Bar length (D) repre sents 30 �m. DG, dentate gyrus granular cell layer; CA 1, CA 1 pyrami dal cell layer . The intensity of histological alterations is ranged from absent (0) to severe (++), as described in the Methods section. Cort, corticosteroid; DG, dentate gyrus; Isch, ischemia; Met, metyrapone; Norm, normoxia; Veh, vehicle.
activity and the amount of reduction were comparable between the experimental groups exposed to hypoxia ischemia.
DISCUSSION
Previous studies in animals demonstrate that high cor ticosteroid hormone levels, presumably using GR, poten tiate brain damage in response to ischemia (Sapolsky and PulsineIli, 1985; ( Morse and Davis, 1990; Sapolsky, 1996) . Preventing the rise in corticosteroid levels during show MAP2 immunoreactivity in the dentate gyrus and CA 1 pyramidal cell layer, respectively, of animals ex posed to normoxia. Photographs (8) and (0) show MAP2 immunoreactivity in vehicle-treated ischemic animals: MAP2 immunoreactivity is reduced mainly in dentate gyrus (8, asterisk) but also in the CA 1 pyramidal cell layer (0) after ischemia. No differ ences in the amount of degeneration was found between the different isch emic groups. Bar length (A) repre sents 30 �m. DG, dentate gyrus granular cell layer; mol, dentate gyrus molecular layer.
ischemia has been reported to reduce cell loss and sei zures after ischemia (Krugers et aI., 1995; Smith Swintosky et aI., 1996; Adachi et aI., 1998; Krugers et aI., 1998) . The glucocorticoid endangerment of neurons is thought to involve an energy-dependent (Sapolsky, 1986; Virgin et aI., 1991) elevation of glutamate concen trations and the subsequent mobilization of toxic intra cellular Ca 2 + levels (Elliott et aI., 1993b; Stein-Behrens et a!., 1992 Adachi et aI., 1998) . From the thera peutic point of view, it is interesting that removal of the adrenal gland after the ischemic insult also prevents neu ronal loss (Sapolsky and PulsineIli, 1985; Morse and Davis, 1990) . The current study was initiated to establish (1) whether therapeutically more relevant steroid modu lations after hypoxia-ischemia also are effective in pre serving neuronal integrity, and (2) whether synaptic function in the hippocampus is preserved along with neu ronal integrity. To test this, we treated animals with a steroid synthesis inhibitor or GR (ant)agonists and ex amined both synaptic transmission and neuronal integrity in the hippocampal CA 1 area 24 hours after hypoxia ischemia as a function of steroid treatment after isch emia.
We found that the steroid synthesis inhibitor metyra pone exerted a (moderately) beneficial effect. First, me tyrapone reduced the incidence and severity of seizure activity immediately after ischemia. Second, the metyra-pone-treated group exhibited the highest survival rate (90%) over the 24-hour survival period and consisted of the largest percentage of animals from which bilateral recordings could be made (67%). Finally, metyrapone prevented the ischemia-induced reduction of the PS am plitude (but not of the fEPSP slope) in the CAl hippo campal field. Taken together, these results indicate that metyrapone administered after ischemia at least initially exerts a beneficial effect. Based on the evidence that metyrapone prevents the ongoing production of cortico sterone (Smith-Swintosky et al., 1996; Krugers et aI., 1995) , we speculate that this effect of metyrapone is related to low plasma corticosteroid levels after isch emia. Measuring plasma corticosterone levels at several time points after ischemia will be necessary to substan tiate this. We did not perform such detailed measure ments, since the procedures to obtain blood samples in combination with ischemia severely compromises the vi ability of animals (unpublished observations). Notice, though, that the protection by metyrapone was only par tial, since 24 hours after ischemia, metyrapone treatment resulted in the highest incidence of seizures and did not prevent the severe loss of neuronal structure.
Since metyrapone, presumably by maintaining low plasma corticosteroid levels after ischemia, reduces del eterious effects of ischemia, we predicted that the syn thetic OR-agonist dexamethasone administered after ischemia should have similar effects. This hypothesis is based on recent findings that dexamethasone is more efficient to activate OR in the pituitary than in the brain based on its poor ability to cross the blood-brain barrier (Meijer et aI., 1998) . If so, dexamethasone would pro mote negative feedback action on the hypothalamopitu itary-adrenal axis activity after stress at the level of the pituitary, thereby reducing the production of endogenous corticosteroids, while at the same time the low dose of the synthetic glucocorticoid is not able to substantially activate brain OR. Our current results do not reveal ben eficial effects of dexamethasone: animals treated with the synthetic OR-agonist showed severe seizure activity, substantial loss of hippocampal integrity, and poor syn aptic transmission 24 hours after the insult. These data extend earlier findings that peripheral dexamethasone treatment increases ischemia-associated structural dam age (Koide et aI., 1986; Packan and Sapolsky, 1990; Adachi et aI., 1998) . One explanation for these observa tions could be that injection with the low dosage of dexa methasone used here (10 fLgimL) only suppresses plasma corticosterone levels with a substantial delay after ad ministration (Meijer et aI., 1998) . This means that high levels of endogenous corticosterone immediately after ischemia can occupy OR and subsequently endanger hip pocampal neurons. This also could explain why dexa methasone-treated animals in many aspects resembled J Cereh Blood Flow Metah. Vol. 19, No. 10. 1999 the animals that received a high dose of corticosterone after ischemia.
Because high plasma corticosterone levels, associated with extensive activation of OR (McEwen et aI., 1986; De Kloet et aI., 1991) , are thought to be involved in the endangering effect of steroids (Packan and Sapolsky, 1990) , blockade of OR with RU 38486 after ischemia should potentially preserve neuronal structure along with synaptic responsiveness. This prediction is supported by observations that RU 38486 protects neurons in vitro against oxidative stress (Behl et aI., 1997) . However, we found that RU 38486 in vivo, administered after isch emia, preserved neither neuronal integrity nor synaptic functioning. The poor efficacy of RU 38486 may be explained in several ways. First, the rise in steroids that accompanies the ischemic insult (Krugers et aI., 1998) presumably activates OR. Therefore, administration of the OR-antagonist RU 38486, which requires time to block OR, at a time point when OR in the brain are already activated may be inefficient. Second, peripher ally injected RU 38486 in control animals is much more efficient in blocking OR at the level of the pituitary than in the brain (Van Haarst et aI., 1997) . In addition, by interfering with the negative feedback action of cortico sterone at the level at the pituitary, RU 38486 treatment may cause a prolonged elevation of plasma corticoste roid levels (Ratka et aI., 1989) . Finally, we should con sider the possibility that OR do not play an important role in the ischemia-induced impairment of synaptic transmission and loss of neuronal integrity. If so, the beneficial effects of metyrapone may result from prop erties other than inhibiting the corticosteroid synthesis. This notion is supported by the inability of both dexa methasone and RU 38486 to alter the outcome of isch emic pathology compared with vehicle-treated controls. Moreover, preliminary evidence suggests that metyra pone treatment in control animals induces anesthesia-like effects (Krugers et aI., 1998) , possibly from a metyra pone-induced accumulation of neuroactive steroids such as II-deoxycorticosterone and its metabolite 3a-21dihydroxy-5a pregnan-20-one. Since these metabolites are known to potentiate OABA A receptor-mediated re sponses (Lambert et aI., 1995) and block voltage dependent Ca 2 + channels (Ffrench-Mullen and Spence, 1991), they may influence the outcome of ischemia.
Whereas preliminary studies show that adrenalectomy after ischemia can exert beneficial effects on celJ struc ture (Sapolsky and Pulsinelli, 1985; Morse and Davis, 1990) , no data were available about the functional prop erties in brain areas that are known to be affected by ischemia. In the current study, we clearly demonstrate that not only neuronal structure, but also synaptic trans mission, is significantly impaired after ischemia. In gen eral, the impaired synaptic functioning appears to be linked to histologic changes. The notion that the im- paired synaptic function might be related to histologic changes rather than changes in neuronal excitability is supported by the absence of group differences in PP responses. Although the methods used allow only quali tative analysis of gross morphologic changes, both the Nissl and the MAP2 staining indicate that animals ex posed to ischemia reveal a high degree of structural dam age, confirming earlier studies (Krugers et a!., 1995 (Krugers et a!., , 1998 Smith-Swintosky et a!., 1996; Adachi et a!., 1998) . The findings that structural damage after ischemia was not only confined to the cell layers, but also present in the dendritic fielp of the hippocampal CA 1 area, may explain the reduction in fEPSP slope in the CAl den dritic field. The extent of neuronal loss after ischemia was not influenced by the steroid treatment, suggesting that synaptic functioning after ischemia generally is im paired along with loss of neuronal structure, despite ste roid treatment. Only metyrapone preserved synaptic functioning in the hippocampal cell layer after ischemia despite loss of neuronal integrity. Hence, this indicates that factors other than neuronal integrity are involved in the preservation of synaptic functioning after treatment with metyrapone.
Whereas the overall data support a correlation be tween neuronal damage and loss in synaptic function after hypoxia-ischemia, detailed evaluation of the data indicates that histologic damage is not a reliable predic tor for loss in synaptic function (and vice versa): ap proximately 20% of the animals showing clear damage in the CAl area still displayed PS amplitudes exceeding 0.40 m V at the ipsilateral side, whereas 20% of the ani mals showing no damage were found to have a loss of synaptic function ipsilateral to the occlusion (Table 5) . Conversely, loss of synaptic function was in approxi mately 15% of the animals not associated with histologic damage. The dissociation between electrophysiologic and histologic observations stresses the need for histo logic and electrophysiologic investigations performed in parallel when interpreting hist o logic changes in terms of functional alterations.
In summary, our current study shows that treatment with the steroid synthesis inhibitor metyrapone has ben eficial effects on ischemia-related pathologic changes and impairment of synaptic transmission, even when the compound is administered after the ischemic insult. From the therapeutic point of view, our results suggest that treatment with steroid synth e sis inhibitors like me tyrapone after ischemia can be useful because they may prolong the window for therapeutic intervention.
